Thermo Fisher to expand clinical research labs

By The Science Advisory Board staff writers

March 16, 2022 -- Thermo Fisher Scientific will invest $97 million to expand its clinical research operations in Richmond, VA. The facilities will support increasing demand across biopharma for consistent, high quality laboratory services to accelerate drug development, the company said.

The company expects to add nearly 150,000 sq ft and more than 500 new employees in Richmond over the next three years. The existing laboratory services operation in Richmond comprises more than 300,000 sq ft, with more than 1,200 employees.

The bulk of the expansion will occur in immunochemistry and chromatography functions, as well as subsequent enhancements in biomarker and vaccine sciences, the company noted.

Thermo Fisher launches new GC and GC-MS portfolios
Thermo Fisher Scientific has launched new gas chromatography (GC) and GC-mass spectrometry (GC-MS) instruments, which offer hardware and software updates.
Thermo Fisher receives accolades for contract manufacturing leadership
For the third consecutive year, Thermo Fisher Scientific’s pharma and biotech customers have recognized its contract manufacturing leadership in all six...
Thermo Fisher supports biopharma discovery with extended collaboration
Thermo Fisher Scientific and Symphogen have agreed to continue their collaboration to provide biopharmaceutical discovery and development laboratories...
Thermo Fisher calls for grant proposals for cancer molecular profiling research
Thermo Fisher Scientific is calling for new proposals for its Oncomine Clinical Research Grant. This builds on the company’s continuous work to support...

Copyright © 2022

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter